Hypotensive side/ priapism effect from antipsychotic | Alpha-1 adrenergic receptor blockade |
Constipation/ dry mouth side effect from antipsychotic (smooth muscle) | M3 receptor blockade |
Sedation side effect (+ a bit of weight gain) | H1 receptor antagonism |
Neuroleptic Malignant Syndrome from antipsychotic/ Irregular period | D2 receptor blockade |
Weight gain side effect | 5HT2C receptor antagonism *mirtazapine |
Sexual dysfunction from SSRI | 5-HT2C receptor agonism *Mirtazapine 5-HT2C receptor antagonist (treatment as adjunct) |
Gastrointestinal side effects | 5-HT3 receptor agonism |
Sexual arousal | cGMP (neuromediator) |
Tiagabine (anticonvulsant) | Inhibition of GAT-1 (inhibitor of GABA uptake) |
Caffeine | Adenosine receptors |
Carbamazepine | Prolonged sodium and calcium channel activation |
Topiramate | Inhibition of kainate mediated conductance at AMPA glutamate receptor |
Valproate | Against Carnitine metabolism - depletes |
Lamotrigine | Rash |
Methadone | Preference in pregnancy |
Lofexidine | used to help with the physical symptoms of opioid withdrawal; treat HTN |
Naltrexone | Alcohol dependence prevention - selective competitive antagonist at mu opioid receptors |
Acamprosate | GABA-like drug that acts on the same glutamatergic NMDA receptor system affected by chronic alcohol use |
Oxazepam | Preferred choice in cirrhosis |
Buprenorphine | Partial opioid agonist acting at the mu opioid receptors
|
Clozapine | Serotonin dopamine agonist with rapid dissociation from D2
Greater risk of seizure above 600 (effective 250 - 550) |
Inverse agonist | Opposite reaction to full agonist |
Partial agonist | Buspirone - 5HT1A partial agonist Aripiprazole - partial dopamine agonist Buprenorphine - partial opioid agonist |
Second messenger system | Lithium |
Allosteric modulator/ non-competitive antagonist | Binds to a receptor at a site distinct from active site |
GABA receptor | Post-synaptic nerve terminal, ligand gated ion channel/ inotropic receptor |
NMDA receptor (glutamate) | Excitatory neurotransmitter; activates ligand gated ion channel |
Muscarinic receptors | G-coupled protein receptors involved in the parasympathetic nervous system |
Partial nicotinic agonist E.g. varenicline (Chantix) | Enhance cognition of schizophrenia (negative symptoms) |
Corticotropin releasing factor | Excessively found in depression |
Orexin | neuropeptide produced in the hypothalamus that regulates the sleep-wake cycle and autonomic functions in the brain. Found more in narcolepsy |
BDNF | neurotransmitter modulator, and participates in neuronal plasticity, which is essential for learning and memory. |
Amisulpride | D2/D3 antagonists Raclopride SPECT |
Norepinephrine | Located in locus coeruleus (upper dorsolateral pontine tegmentum) Major role in arousal, attention and stress response |
Recall bias | Cases and control recall differently |
Rumination bias/ Search for meaning | People with disease will think harder about their prior exposures than disease free people |
Attrition bias | selective dropout of some participants who systematically differ from those who remain in the study E.g. cannabis use drop out quicker than schizophrenia |
Berkson’s bias | when hospital controls are used in a case-control study - more likely sampling bias |
Neyman bias | a selection bias where the very sick or very well (or both) are erroneously excluded from a study E.g. people smoking dies early thus difficult to see the correlation with Alzehimer |
Selection bias | the selection of individuals, groups, or data for analysis in such a way that proper randomization is not achieved |
OCD side effects | 5HT1D stimulation |
Ventral Tegmental Area (VTA) | Reward system/ addiction - dopaminergic neurons Neurons rich in dopamine project from this area to the nigrostriatal pathway When doing nothing, dopamine neurons in VTA activated and projected to nucleus accumbens -> increased dopamine in NA = mesolimbic pathway |
Anterior Cingulate Function | Detection of errors, anticipation/ preparation before task performance, regulation of emotions |
Hippocampus | Memory |
Amygdala | emotions/ emotional behaviour/ motivation |
Lateral geniculate nucleus | Part of thalamus Involved in visual processing |
Medial geniculate nucleus | Involved in auditory processing |
Ventromedial thalamus | Satiety and hunger |
Lateral nucleus hypothalamus | Hunger and thirst |
Hypothalamus | Laughing seizure |
Orbitofrontal cortex | Disinhibited/ impulsive |
Medial frontal cortex | Akinetic mutism |
Dorsolateral cortex | Deficits in executive function (frontodemporal) |
Thalamus | Sensory/ pain |
Inferior olivary nuclues (of cerebellum) | Finger to nose test |
Subcortical leukoencephalopathy/ white matter hyperintensities | Associated with late life depression A small vessel vascular dementia |
Schizophrenia | Reduced phospholipids |
Anxiety | Increased activity in insula and amygdala |
Mood disorder | Medial pre frontal cortex dysfunction |
Autism | Increased brain volume/ cortical surface area |
Eating disorder | Increase in 5-HT1a (stress/ anti-aggression) and decrease in 5-HT2a (active coping/ cognitive flexibility) |
OCPD - anankastic | |
HSE abnormalities | Spike and slow or periodic sharp wave patterns over temporal lobes/ diffuse slowing delta waves |
Subacute Sclerosing Pan Encephalitis (SSPE) | Periodic high amplitude delta waves |
Absence seizures | Generalised 3Hz spike and wave complexes |
Anti-NMDA encephalitis | Associated with ovarian tumours |
Neurosyphilis | Foot drops, absent light pupil reflex CSF VDRL |
Huntington | Dysphoria (poor mood), ataxia, tremor SPECT - caudate and putamen hypometabolism |
Hyperprolactinaemia/ prolactinoma | MRI Sella Turcica |
Multiple sclerosis | Confusion, asymmetrical lateral gaze, ataxia, numbness FLAIR (more sensitive than T2) - detection of periventricular plaques MRI T2 weighted - hyperintense lesions |
vCJD | MRI Pulvinar nuclei of thalamus - high intensity signal bilaterally |
Alzheimer | Dopamine transporter scan - differentiates from Lewy Body Major cholinergic site involved in cerebral cortex - Nucleus basalis of Meynert (reduced in Alzheimer) |
Parkinson | Hypokinesia |
Lewy body | Asymmetric resting tremor |
Kluver Bucy Syndrome | Bilateral lesions of anterior temporal lobe Visual agnosia, excessive oral tendency, hypermetamorphosis, loss of normal fear response, hypersexuality, changes in eating behaviour |
Persecutory spiral | If the therapist himself feels persecuted by the patient and 'responds by overt and covert attack' |
Senile chorea | Gradual onset of generalised and symmetric chorea with slow progression |
Parkinson’s disease | Associated with SSRI use |
Tardive dyskinesia | Orobuccolingual, truncal, appendicular/ limbs, choreiform movements (writhing movements) |
Tardive dystonia | Sustained stereotyped muscle spasms of twisting or turning character (e.g. blinking, cramping of foot, pulling of neck)
|
Tardive akathisia | inner sense of restlessness or unease |
Hemiballismus | Swinging movements - sub thalamic nucleus |
Rapid eye movement sleep disorder | REM Active arousal during sleep associated with vocalisation/ complex motor behaviours
|
Restless leg syndrome | Treatment
|
Wernicke’s aphasia/ receptive aphasia | Impaired comprehension, normal speech, repetition impaired |
Broca’s aphasia | Unable to speak fluently, repetition impaired
|
Conduction aphasia | Comprehension intact and normal speech Repetition impaired |
Transcortical motor aphasia | Wernicke’s + normal repetition, prominent echolalia |
Anosognosia | Lack of awareness of disease |
Hemiasomatognosia | Feels like one side of limbs missing Involvement of parietal lobe |
Associative visual agnosia | Perception intact but does not recognise the object (the purpose) |